Confidence Over Pfizer's Efficacy Against UK COVID Strain: BioNTech

Amidst the fear of a new COVID-19 strain spreading in the UK, BioNTech CEO Ugur Sahin said that the company has "Scientific confidence" that Pfizer vaccine will work against the new variant as well. However, the efficacy can be confirmed only after studies, he added. Moreover, the company is ready to make changes in the vaccine to tackle the new strain of COVID-19, subject to the approval by the regulators.